Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Bix

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Clinical Investigation|July 13, 2011
Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodentsBoyeon Lee, Douglas Clarke, Abraham Al Ahmad, et al.
Neuroreport|May 31, 2012
Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissueMichael P Kahle, Boyeon Lee, Tony Pourmohamad, et al.
Journal of Neurointerventional Surgery|August 2, 2018
The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC) protocol: novel method for evaluating human strokeJustin F Fraser, Lisa A Collier, Amy A Gorman, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zoneVivianne E Morrison, Matthew G Houpert, Jonathan B Trapani, et al.
Frontiers in Neurology|March 6, 2025
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeuticsGrant McGee Talkington, Paresh Kolluru, Timothy E Gressett, et al.
Translational Stroke Research|April 8, 2020
Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in MiceAmanda L Trout, Michael P Kahle, Jill M Roberts, et al.
Nature Communications|April 2, 2022
Neuropathology and virus in brain of SARS-CoV-2 infected non-human primatesIbolya Rutkai, Meredith G Mayer, Linh M Hellmers, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Clinical Investigation|July 13, 2011
Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodentsBoyeon Lee, Douglas Clarke, Abraham Al Ahmad, et al.
Neuroreport|May 31, 2012
Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissueMichael P Kahle, Boyeon Lee, Tony Pourmohamad, et al.
Journal of Neurointerventional Surgery|August 2, 2018
The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC) protocol: novel method for evaluating human strokeJustin F Fraser, Lisa A Collier, Amy A Gorman, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zoneVivianne E Morrison, Matthew G Houpert, Jonathan B Trapani, et al.
Frontiers in Neurology|March 6, 2025
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeuticsGrant McGee Talkington, Paresh Kolluru, Timothy E Gressett, et al.
Translational Stroke Research|April 8, 2020
Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in MiceAmanda L Trout, Michael P Kahle, Jill M Roberts, et al.
Nature Communications|April 2, 2022
Neuropathology and virus in brain of SARS-CoV-2 infected non-human primatesIbolya Rutkai, Meredith G Mayer, Linh M Hellmers, et al.
Pageof 6